Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

被引：0
|
作者：
Li Shen Loo
Jessica Ailani
Jack Schim
Simin Baygani
Hans-Peter Hundemer
Martha Port
John H. Krege
机构：
[1] Lilly Research Laboratories,
[2] Lilly Corporate Center,undefined
[3] MedStar Georgetown University Hospital,undefined
[4] The Neurology Center of Southern California,undefined
[5] Lilly Deutschland GmbH,undefined
[6] Medical Department,undefined
来源：
The Journal of Headache and Pain | 2019年 / 20卷
关键词：
Acute treatment; Concomitant; Ditan; Efficacy; Lasmiditan; Migraine; Migraine medication; Migraine preventive; Migraine prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
    Loo, Li Shen
    Ailani, Jessica
    Schim, Jack
    Baygani, Simin
    Hundemer, Hans-Peter
    Port, Martha
    Krege, John H.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1): : 84
  • [2] Efficacy and Safety of Lasmiditan in Patients on Concomitant Migraine Preventive Medications: Findings from SAMURAI and SPARTAN Phase 3 Trials
    Schim, J.
    Ailani, J.
    Loo, L.
    Krege, J. H.
    Baygani, S.
    Hundemer, H.
    Port, M.
    [J]. HEADACHE, 2019, 59 : 109 - 110
  • [3] Efficacy and safety of lasmiditan in patients on migraine preventive medications: findings from SAMURAI and SPARTAN Phase 3 trials
    Ailani, Jessica
    Loo, Li Shen
    Krege, John H.
    Baygani, Simin
    Hundemer, Hans-Peter
    Port, Martha
    Schim, Jack
    [J]. CEPHALALGIA, 2019, 39 : 8 - 8
  • [4] Effect of a Rescue or Recurrence Dose of Lasmiditan on Efficacy and Safety in the Acute Treatment of Migraine: Findings from the Phase 3 Trials (SAMURAI and SPARTAN)
    Loo, L.
    Plato, B. M.
    Turner, I. M.
    Case, M. G.
    Raskin, J.
    Dowsett, S. A.
    Krege, J. H.
    [J]. HEADACHE, 2019, 59 : 94 - 95
  • [5] Safety Findings from the Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan for Acute Treatment of Migraine
    Krege, John H.
    Liffick, Emily
    Doty, Erin G.
    Dowsett, Sherie A.
    Wang, Jia Ning
    Buchanan, Andrew S.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [6] Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)
    Loo, Li Shen
    Plato, Brian M.
    Turner, Ira M.
    Case, Michael G.
    Raskin, Joel
    Dowsett, Sherie A.
    Krege, John H.
    [J]. BMC NEUROLOGY, 2019, 19 (01)
  • [7] Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)
    Li Shen Loo
    Brian M. Plato
    Ira M. Turner
    Michael G. Case
    Joel Raskin
    Sherie A. Dowsett
    John H. Krege
    [J]. BMC Neurology, 19
  • [8] Safety Findings from the Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan for Acute Treatment of Migraine
    Rizzoli, P.
    Krege, J. H.
    Doty, E. Gautier
    Liffick, E.
    Dowsett, S. A.
    Wang, J.
    Buchanan, A. S.
    [J]. HEADACHE, 2019, 59 : 96 - 96
  • [9] Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN
    Krege, John H.
    Rizzoli, Paul B.
    Liffick, Emily
    Doty, Erin G.
    Dowsett, Sherie A.
    Wang, Jianing
    Buchanan, Andrew S.
    [J]. CEPHALALGIA, 2019, 39 (08) : 957 - 966
  • [10] Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials
    Tepper, Stewart J.
    Krege, John H.
    Lombard, Louise
    Asafu-Adjei, Josephine K.
    Dowsett, Sherie A.
    Raskin, Joel
    Buchanan, Andrew S.
    Friedman, Deborah I.
    [J]. HEADACHE, 2019, 59 (07): : 1052 - 1062
12345